Physician profile
Robert A Kitei
NPI 1093777088
$1,291.57
in general payments reported to CMS, 2019-2025
17 companies · $233 in 2025
The $233 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $140 · 2020: $123 · 2021: $168 · 2022: $66.74 · 2023: $370 · 2024: $191 · 2025: $233.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $794.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $794.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $296.47 | 2023-2025 | |
| Sun Pharmaceutical Industries INC. | $196.19 | 2019-2023 | Cequa |
| Alcon Vision LLC | $155.98 | 2020-2025 | Clareon, Tryptyr, Eysuvis |
| Rxsight INC | $125.45 | 2023 | Rxsight Injector Cartridge, Rxsight Contact Lens, Rxsight Light Adjustable Lens (Rxlal) |
| Kala Pharmaceuticals, INC. | $94.05 | 2019-2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $76.26 | 2019-2021 | |
| Tarsus Pharmaceuticals, INC. | $62.28 | 2024-2025 | Xdemvy |
| Topcon Healthcare, INC. | $46.35 | 2020 | |
| Horizon Therapeutics Plc | $45.29 | 2020-2023 | Tepezza |
| Sandoz INC. | $42.04 | 2024 | Cimerli |
| Allergan, INC. | $29.74 | 2019-2020 | |
| Omeros Corporation | $27.54 | 2021 | |
| Sight Sciences, INC. | $27.07 | 2019-2021 | |
| Lkc Technologies, INC. | $22.16 | 2025 | |
| Alexion Pharmaceuticals, INC. | $17.90 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $14.84 | 2019 | |
| Novartis Pharmaceuticals Corporation | $11.96 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Kitei listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.